Mapping endpoints: building gene therapy trials for the future
How can gene therapy trials choose the best endpoints to navigate development and demonstrate patient value?
Five gene therapy trial readouts to watch in the first half of 2023
Renexxion reveals clinical development plans to address GI symptoms in cystic fibrosis patients
Pipeline Moves: Trial completion bumps advancement prospects for AstraZeneca’s oncology drug
DCTs in 2023: New year’s resolutions for decentralised clinical trials
New year, new trials: Analysis reveals clinical trial activity trends in 2023
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreDyadic initiates subject dosing in Phase I trial of Covid-19 booster
The trial will include healthy subjects aged 18 to 55 years who will be randomised in 4:1 ratio, with 15 subjects per cohort.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
Shionogi commences Phase I/II/III and Phase III trials of Covid-19 vaccine
Ascletis doses subjects in first cohort of Covid-19 oral therapy trial